Fresenius Kabi announced on April 22, 2018 that it has decided to terminate the company s previously announced merger agreement with Akorn, a United States-based manufacturer and marketer of prescription and over-the-counter pharmaceutical products.
Fresenius stated that the decision iOriginal Article
